Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024
Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024
Summit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned Executive and Genomicist, to its Board of Directors
Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum
Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed
Intracranial Anti-Tumor Activity and Safety of Ivonescimab in NSCLC
Summit to Present at the Barclays 26th Annual Global Healthcare Conference
Summit Therapeutics Reports Financial Results for the Fourth Quarter
Summit Therapeutics to Host Fourth Quarter & Full Year 2023 Financial Results
Summit to Present at Oppenheimer’s 34th Annual Life Sciences Conference